Menu Search
Equities

TATA Health International Holdings Ltd

1255:HKG.HS

TATA Health International Holdings Ltd

Actions
  • Price (HKD)0.300
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-24.05%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TATA Health International Holdings Ltd, formerly S. Culture International Holdings Ltd, is an investment holding company principally engaged in the sale of footwear products. The Company operates business through four segments. The Footwear Business segment is involved in the sale of footwear products under the brand name of Clarks, Josef Seibel, The Flexx and Petite Jolie. The Financial Services Business segment is involved in the provision of advisory services in securities, investment management services and advisory services in corporate finance. The Healthcare Business segment is involved in the sale of healthcare products under the brand name of AXS and Bio Lands and others, and Aptamil milk powder. The Online Medical Services Business segment provides medical services such as medical advisory and consultation.

  • Revenue in HKD (TTM)185.22m
  • Net income in HKD-22.88m
  • Incorporated2012
  • Employees120.00
  • Location
    TATA Health International Holdings LtdFlat F-J, 11F,Kwai Tak Industrial Centre15-33 Kwai Tak Street, Kwai ChungNew TerritoriesHong kong Hong KongHKG
  • Phone+852 26120003
  • Websitehttp://www.s-culture.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.